Works matching AU Nakatomi, Katsumi

Results: 31

Analysis of Intratumor Heterogeneity of EGFR Mutations in Mixed Type Lung Adenocarcinoma.

Published in:

Clinical Lung Cancer, 2013, v. 14, n. 5, p. 521, doi. 10.1016/j.cllc.2013.04.005

By:

Nanae Tomonaga;
Yoichi Nakamura;
Hiroyuki Yamaguchi;
Takaya Ikeda;
Kosuke Mizoguchi;
Kohei Motoshima;
Seiji Doi;
Katsumi Nakatomi;
Tetsuya Iida;
Tomayoshi Hayashi;
Takeshi Nagayasu;
Kazuhiro Tsukamoto;
Shigeru Kohno

Publication type:

Article

Adverse renal effects of anaplastic lymphoma kinase inhibitors and the response to alectinib of an ALK+ lung cancer patient with renal dysfunction.

Published in:

OncoTargets & Therapy, 2017, v. 10, p. 3211, doi. 10.2147/OTT.S136837

By:

Takaya Ikeda;
Hiroyuki Yamaguchi;
Katsumi Nakatomi;
Hiroshi Mukae;
Midori Shimada;
Masaaki Fukuda;
Takeshi Kitazaki;
Kohji Hashiguchi;
Minoru Fukuda;
Kazuto Ashizawa

Publication type:

Article

Second-line immunosuppressant administration for steroid-refractory immune-related adverse events in patients with lung cancer.

Published in:

Cancer Immunology, Immunotherapy, 2023, v. 72, n. 11, p. 3765, doi. 10.1007/s00262-023-03528-x

By:

Ogusu, Shinsuke;
Harutani, Yuhei;
Tozuka, Takehiro;
Saito, Ryota;
Koyama, Junji;
Sakamoto, Hiroaki;
Sonoda, Tomoaki;
Tsuchiya-Kawano, Yuko;
Oba, Tomohiro;
Kudo, Keita;
Gyotoku, Hiroshi;
Nakatomi, Katsumi;
Ariyasu, Ryo

Publication type:

Article

Baseline genetic abnormalities and effectiveness of osimertinib treatment in patients with chemotherapy-naïve EGFR-mutated NSCLC based on performance status.

Published in:

BMC Pulmonary Medicine, 2024, v. 24, n. 1, p. 1, doi. 10.1186/s12890-024-03212-5

By:

Taniguchi, Yoshihiko;
Tamiya, Akihiro;
Osuga, Mitsuo;
Harada, Daijiro;
Isa, Shun-ichi;
Nakamura, Keiichi;
Mizumori, Yasuyuki;
Shinohara, Tsutomu;
Yanai, Hidetoshi;
Nakatomi, Katsumi;
Oki, Masahide;
Mori, Masahide;
Kuwako, Tomohito;
Yamazaki, Koji;
Tamura, Atsuhisa;
Ando, Masahiko;
Koh, Yasuhiro

Publication type:

Article

Methylation status of breast cancer resistance protein detected by methylation-specific polymerase chain reaction analysis is correlated inversely with its expression in drug-resistant lung cancer cells.

Published in:

2008

By:

Nakano, Hirofumi;
Nakamura, Yoichi;
Soda, Hiroshi;
Kamikatahira, Megumi;
Uchida, Kanako;
Takasu, Mineyo;
Kitazaki, Takeshi;
Yamaguchi, Hiroyuki;
Nakatomi, Katsumi;
Yanagihara, Katsunori;
Kohno, Shigeru;
Tsukamoto, Kazuhiro

Publication type:

journal article

Dose escalation study of amrubicin and cisplatin with concurrent thoracic radiotherapy for limited-disease small cell lung cancer.

Published in:

2019

By:

Shimada, Midori;
Yamaguchi, Hiroyuki;
Fukuda, Minoru;
Tomono, Hiromi;
Honda, Noritaka;
Dotsu, Yosuke;
Taniguchi, Hirokazu;
Gyotoku, Hiroshi;
Senju, Hiroaki;
Takemoto, Shinnosuke;
Ikeda, Takaya;
Nakatomi, Katsumi;
Nakamura, Yoichi;
Nagashima, Seiji;
Yamazaki, Takuya;
Mukae, Hiroshi

Publication type:

journal article

Pharmacokinetic parameters of gefitinib predict efficacy and toxicity in patients with advanced non-small cell lung cancer harboring EGFR mutations.

Published in:

2016

By:

Mizoguchi, Kosuke;
Nakamura, Yoichi;
Sano, Kazumi;
Sato, Shuntaro;
Ikegami, Yoji;
Motoshima, Kohei;
Takemoto, Shinnosuke;
Ogawara, Daiki;
Senju, Hiroaki;
Sugasaki, Nanae;
Ikeda, Takaya;
Yamaguchi, Hiroyuki;
Nakatomi, Katsumi;
Fukuda, Minoru;
Izumikawa, Koichi;
Mukae, Hiroshi

Publication type:

journal article

A phase II study of amrubicin and carboplatin for previously untreated patients with extensive-disease small cell lung cancer.

Published in:

Cancer Chemotherapy & Pharmacology, 2014, v. 74, n. 3, p. 497, doi. 10.1007/s00280-014-2527-4

By:

Ikeda, Takaya;
Fukuda, Minoru;
Nakamura, Yoichi;
Kinoshita, Akitoshi;
Senju, Hiroaki;
Nakano, Hirofumi;
Kitazaki, Takeshi;
Ogawara, Daiki;
Taniguchi, Hirokazu;
Motoshima, Kohei;
Yamaguchi, Hiroyuki;
Nakatomi, Katsumi;
Shimada, Midori;
Nagashima, Seiji;
Tsukamoto, Kazuhiro;
Kohno, Shigeru

Publication type:

Article

Serum levels of surfactant protein D predict the anti-tumor activity of gefitinib in patients with advanced non-small cell lung cancer.

Published in:

Cancer Chemotherapy & Pharmacology, 2011, v. 67, n. 2, p. 331, doi. 10.1007/s00280-010-1325-x

By:

Yamaguchi, Hiroyuki;
Soda, Hiroshi;
Nakamura, Yoichi;
Takasu, Mineyo;
Tomonaga, Nanae;
Nakano, Hirofumi;
Doi, Seiji;
Nakatomi, Katsumi;
Nagashima, Seiji;
Takatani, Hiroshi;
Fukuda, Minoru;
Hayashi, Tomayoshi;
Tsukamoto, Kazuhiro;
Kohno, Shigeru

Publication type:

Article

A Phase II Study of S-1 for Previously Untreated Elderly Patients with Advanced Non-Small Cell Lung Cancer.

Published in:

Chemotherapy (0009-3157), 2016, v. 61, n. 2, p. 93, doi. 10.1159/000441486

By:

Kasai, Takashi;
Nakamura, Yoichi;
Fukuda, Minoru;
Kitazaki, Takeshi;
Nagashima, Seiji;
Takatani, Hiroshi;
Nakano, Hirofumi;
Nakatomi, Katsumi;
Ikeda, Takaya;
Yamaguchi, Hiroyuki;
Tsukamoto, Kazuhiro;
Oka, Mikio;
Kohno, Shigeru

Publication type:

Article

Phase I/II Study of Amrubicin and Nedaplatin in Patients with Untreated, Advanced, Non-Small Cell Lung Cancer.

Published in:

Chemotherapy (0009-3157), 2015, v. 60, n. 3, p. 180, doi. 10.1159/000371870

By:

Ogawara, Daiki;
Nakamura, Yoichi;
Fukuda, Minoru;
Nakatomi, Katsumi;
Yamaguchi, Hiroyuki;
Motoshima, Kohei;
Mizoguchi, Kosuke;
Nakano, Hirofumi;
Takemoto, Shinnosuke;
Gyotoku, Hiroshi;
Nagashima, Seiji;
Kohno, Shigeru

Publication type:

Article

Circulating Tumour DNA in Patients With EGFR‐Mutated Non‐Small‐Cell Lung Cancer and Early Disease Progression After First‐Line Osimertinib Treatment: The ELUCIDATOR Multicentre Prospective Observational Study.

Published in:

Cancer Medicine, 2025, v. 14, n. 7, p. 1, doi. 10.1002/cam4.70861

By:

Tamiya, Akihiro;
Mizumori, Yasuyuki;
Osuga, Mitsuo;
Isa, Shun‐ichi;
Taniguchi, Yoshihiko;
Nakamura, Keiichi;
Harada, Daijiro;
Shinohara, Tsutomu;
Yanai, Hidetoshi;
Nakatomi, Katsumi;
Oki, Masahide;
Mori, Masahide;
Kuwako, Tomohito;
Yamazaki, Koji;
Tamura, Atsuhisa;
Ando, Masahiko;
Koh, Yasuhiro

Publication type:

Article

Prophylactic treatment of dacomitinib‐induced skin toxicities in epidermal growth factor receptor‐mutated non–small‐cell lung cancer: A multicenter, Phase II trial.

Published in:

Cancer Medicine, 2023, v. 12, n. 14, p. 15117, doi. 10.1002/cam4.6184

By:

Iwasaku, Masahiro;
Uchino, Junji;
Chibana, Kenji;
Tanzawa, Shigeru;
Yamada, Takahiro;
Tobino, Kazunori;
Uchida, Yasuki;
Kijima, Takashi;
Nakatomi, Katsumi;
Izumi, Miiru;
Tamiya, Nobuyo;
Kimura, Hideharu;
Fujita, Masaki;
Honda, Ryoichi;
Takumi, Chieko;
Yamada, Tadaaki;
Kaneko, Yoshiko;
Kiyomi, Fumiaki;
Takayama, Koichi

Publication type:

Article

Real-World Incidence of Febrile Neutropenia among Patients Treated with Single-Agent Amrubicin: Necessity of the Primary Prophylactic Administration of Granulocyte Colony-Stimulating Factor.

Published in:

Journal of Clinical Medicine, 2021, v. 10, n. 18, p. 4221, doi. 10.3390/jcm10184221

By:

Dotsu, Yosuke;
Yamaguchi, Hiroyuki;
Fukuda, Minoru;
Suyama, Takayuki;
Honda, Noritaka;
Umeyama, Yasuhiro;
Taniguchi, Hirokazu;
Gyotoku, Hiroshi;
Takemoto, Shinnosuke;
Tagawa, Ryuta;
Ogata, Ryosuke;
Tomono, Hiromi;
Shimada, Midori;
Senju, Hiroaki;
Nakatomi, Katsumi;
Nagashima, Seiji;
Soda, Hiroshi;
Ikeda, Hiroaki;
Ashizawa, Kazuto;
Mukae, Hiroshi

Publication type:

Article

Prediction of Anti-Cancer Drug-Induced Pneumonia in Lung Cancer Patients: Novel High-Resolution Computed Tomography Fibrosis Scoring.

Published in:

Journal of Clinical Medicine, 2020, v. 9, n. 4, p. 1045, doi. 10.3390/jcm9041045

By:

Gyotoku, Hiroshi;
Yamaguchi, Hiroyuki;
Ishimoto, Hiroshi;
Sato, Shuntaro;
Taniguchi, Hirokazu;
Senju, Hiroaki;
Kakugawa, Tomoyuki;
Nakatomi, Katsumi;
Sakamoto, Noriho;
Fukuda, Minoru;
Obase, Yasushi;
Soda, Hiroshi;
Ashizawa, Kazuto;
Mukae, Hiroshi

Publication type:

Article

Secondary EML4–ALK-positive Lung Adenocarcinoma in a Patient Previously Treated for Acute Lymphoblastic Leukemia in Childhood: A Case Report.

Published in:

Japanese Journal of Clinical Oncology, 2014, v. 44, n. 6, p. 593, doi. 10.1093/jjco/hyu028

By:

Nakamura, Yoichi;
Taniguchi, Hirokazu;
Mizoguchi, Kosuke;
Ikeda, Takaya;
Motoshima, Kohei;
Yamaguchi, Hiroyuki;
Nagashima, Seiji;
Nakatomi, Katsumi;
Soda, Manabu;
Mano, Hiroyuki;
Kohno, Shigeru

Publication type:

Article

Phase II study of IRInotecan treatment after COmbined chemo‐immunotherapy for extensive‐stage small cell lung cancer: Protocol of IRICO study.

Published in:

Thoracic Cancer, 2023, v. 14, n. 28, p. 2890, doi. 10.1111/1759-7714.15097

By:

Tomono, Hiromi;
Taniguchi, Hirokazu;
Fukuda, Minoru;
Ikeda, Takaya;
Nagashima, Seiji;
Akagi, Kazumasa;
Ono, Sawana;
Umeyama, Yasuhiro;
Shimada, Midori;
Gyotoku, Hiroshi;
Takemoto, Shinnosuke;
Hisamatsu, Yasushi;
Morinaga, Ryotaro;
Tagawa, Ryuta;
Ogata, Ryosuke;
Dotsu, Yosuke;
Senju, Hiroaki;
Soda, Hiroshi;
Nakatomi, Katsumi;
Hayashi, Fumiko

Publication type:

Article

Efficacy of S‐1 after pemetrexed in patients with non‐small cell lung cancer: A retrospective multi‐institutional analysis.

Published in:

Thoracic Cancer, 2021, v. 12, n. 17, p. 2300, doi. 10.1111/1759-7714.14055

By:

Takemoto, Shinnosuke;
Akagi, Kazumasa;
Ono, Sawana;
Tomono, Hiromi;
Honda, Noritaka;
Suyama, Takayuki;
Umeyama, Yasuhiro;
Dotsu, Yosuke;
Taniguchi, Hirokazu;
Ogawara, Daiki;
Senju, Hiroaki;
Gyotoku, Hiroshi;
Sugasaki, Nanae;
Yamaguchi, Hiroyuki;
Nakatomi, Katsumi;
Fukuda, Minoru;
Mukae, Hiroshi

Publication type:

Article

Phase II study of ramucirumab and docetaxel for previously treated non‐small cell lung cancer patients with malignant pleural effusion: Protocol of PLEURAM study.

Published in:

Thoracic Cancer, 2020, v. 11, n. 2, p. 389, doi. 10.1111/1759-7714.13279

By:

Takemoto, Shinnosuke;
Fukuda, Minoru;
Yamaguchi, Hiroyuki;
Ikeda, Takaya;
Akagi, Kazumasa;
Tomono, Hiromi;
Umeyama, Yasuhiro;
Dotsu, Yosuke;
Taniguchi, Hirokazu;
Gyotoku, Hiroshi;
Senju, Hiroaki;
Kitazaki, Takeshi;
Nakatomi, Katsumi;
Nagashima, Seiji;
Fukuda, Masaaki;
Kinoshita, Akitoshi;
Soda, Hiroshi;
Mukae, Hiroshi

Publication type:

Article

Phase II study of nedaplatin and amrubicin as first‐line treatment for advanced squamous cell lung cancer.

Published in:

Thoracic Cancer, 2019, v. 10, n. 9, p. 1764, doi. 10.1111/1759-7714.13134

By:

Taniguchi, Hirokazu;
Yamaguchi, Hiroyuki;
Dotsu, Yosuke;
Shimada, Midori;
Gyotoku, Hiroshi;
Senju, Hiroaki;
Takemoto, Shinnosuke;
Kitazaki, Takeshi;
Fukuda, Masaaki;
Ogawara, Daiki;
Soda, Hiroshi;
Nakatomi, Katsumi;
Sugasaki, Nanae;
Kinoshita, Akitoshi;
Nagashima, Seiji;
Ikeda, Takaya;
Nakamura, Yoichi;
Sakamoto, Noriho;
Obase, Yasushi;
Fukuda, Minoru

Publication type:

Article

Phase II trial of a non‐platinum triplet for patients with advanced non‐small cell lung carcinoma (NSCLC) overexpressing ERCC1 messenger RNA.

Published in:

Thoracic Cancer, 2019, v. 10, n. 3, p. 452, doi. 10.1111/1759-7714.12958

By:

Takemoto, Shinnosuke;
Nakamura, Yoichi;
Gyoutoku, Hiroshi;
Senju, Hiroaki;
Ogawara, Daiki;
Ikeda, Takaya;
Yamaguchi, Hiroyuki;
Kitazaki, Takeshi;
Nakano, Hirofumi;
Nakatomi, Katsumi;
Tomari, Shinya;
Sato, Shuntaro;
Nagashima, Seiji;
Fukuda, Minoru;
Mukae, Hiroshi

Publication type:

Article

Relationship between UGT1A127 and UGT1A17 polymorphisms and irinotecan-related toxicities in patients with lung cancer.

Published in:

Thoracic Cancer, 2018, v. 9, n. 1, p. 51, doi. 10.1111/1759-7714.12535

By:

Fukuda, Minoru;
Okumura, Manabu;
Iwakiri, Tomomi;
Arimori, Kazuhiko;
Honda, Takuya;
Kobayashi, Kazuma;
Senju, Hiroaki;
Takemoto, Shinnosuke;
Ikeda, Takaya;
Yamaguchi, Hiroyuki;
Nakatomi, Katsumi;
Matsuo, Nobuko;
Mukae, Hiroshi;
Ashizawa, Kazuto

Publication type:

Article

Phase I study of pemetrexed and concurrent radiotherapy for previously untreated elderly patients with locally advanced non-squamous non-small cell lung cancer.

Published in:

Thoracic Cancer, 2017, v. 8, n. 6, p. 577, doi. 10.1111/1759-7714.12483

By:

Takemoto, Shinnosuke;
Nakamura, Yoichi;
Fukuda, Minoru;
Senju, Hiroaki;
Gyotoku, Hiroshi;
Taniguchi, Hirokazu;
Shimada, Midori;
Ikeda, Takaya;
Yamaguchi, Hiroyuki;
Nakatomi, Katsumi;
Hayashi, Nobuyuki;
Soda, Hiroshi;
Mukae, Hiroshi

Publication type:

Article

Autoantibody to Heat Shock Protein Hsp40 in Sera of Lung Cancer Patients.

Published in:

Cancer Science, 2001, v. 92, n. 3, p. 316, doi. 10.1111/j.1349-7006.2001.tb01097.x

By:

Oka, Mikio;
Sato, Sho-ichi;
Soda, Hiroshi;
Fukuda, Minoru;
Kawabata, Shigeru;
Nakatomi, Katsumi;
Shiozawa, Ken;
Nakamura, Yo-ichi;
Ohtsuka, Kenzo;
Kohno, Shigeru

Publication type:

Article

Birth Cohort Effects on Incidence of Lung Cancers: A Population-based Study in Nagasaki, Japan.

Published in:

Cancer Science, 2000, v. 91, n. 10, p. 960, doi. 10.1111/j.1349-7006.2000.tb00871.x

By:

Soda, Hiroshi;
Oka, Mikio;
Soda, Midori;
Nakatomi, Katsumi;
Kawabata, Shigeru;
Suenaga, Mitsuhiro;
Kasai, Takashi;
Yamada, Yasuaki;
Kamihira, Shimeru;
Kohno, Shigeru

Publication type:

Article

Stage-specific efficacy of osimertinib in treatment-naïve EGFR-mutant non-small cell lung cancer according to baseline genetic alterations in circulating tumor DNA.

Published in:

Investigational New Drugs, 2025, v. 43, n. 1, p. 101, doi. 10.1007/s10637-024-01500-9

By:

Taniguchi, Yoshihiko;
Tamiya, Akihiro;
Osuga, Mitsuo;
Isa, Shun-ichi;
Nakamura, Keiichi;
Mizumori, Yasuyuki;
Shinohara, Tsutomu;
Yanai, Hidetoshi;
Nakatomi, Katsumi;
Oki, Masahide;
Mori, Masahide;
Kuwako, Tomohito;
Yamazaki, Koji;
Shimada, Masahiro;
Ando, Masahiko;
Koh, Yasuhiro

Publication type:

Article

Drug fever after cancer chemotherapy is most commonly observed on posttreatment days 3 and 4.

Published in:

2016

By:

Ogawara, Daiki;
Fukuda, Minoru;
Ueno, Shiro;
Ohue, Yoshihiro;
Takemoto, Shinnosuke;
Mizoguchi, Kosuke;
Nakatomi, Katsumi;
Nakamura, Yoichi;
Obase, Yasushi;
Honda, Takuya;
Tsukamoto, Kazuhiro;
Ashizawa, Kazuto;
Oka, Mikio;
Kohno, Shigeru

Publication type:

journal article

Treatment with gefitinib after erlotinib-induced liver injury: a case report.

Published in:

2011

By:

Nakatomi, Katsumi;
Nakamura, Yoichi;
Tetsuya, Iida;
Kohno, Shigeru

Publication type:

journal article

Reversal of breast cancer resistance protein (BCRP/ABCG2)-mediated drug resistance by novobiocin, a coumermycin antibiotic.

Published in:

International Journal of Cancer, 2004, v. 108, n. 1, p. 146, doi. 10.1002/ijc.11528

By:

Ken Shiozawa;
Mikio Oka;
Hiroshi Soda;
Megumi Yoshikawa;
Yoji Ikegami;
Junji Tsurutani;
Katsumi Nakatomi;
Yoichi Nakamura;
Seiji Doi;
Takeshi Kitazaki;
Yohei Mizuta;
Kunihiko Murase;
Hisahiro Yoshida;
Douglas D. Ross;
Shigeru Kohno

Publication type:

Article

Antiproliferative effects of the histone deacetylase inhibitor FR901228 on small-cell lung cancer lines and drug-resistant sublines.

Published in:

International Journal of Cancer, 2003, v. 104, n. 2, p. 238, doi. 10.1002/ijc.10921

By:

Tsurutani, Junji;
Soda, Hiroshi;
Oka, Mikio;
Suenaga, Mitsuhiro;
Doi, Seiji;
Nakamura, Yoichi;
Nakatomi, Katsumi;
Shiozawa, Ken;
amada, Yasuaki Y;
Kamihira, Shimeru;
Kohno, Shigeru

Publication type:

Article

Histone deacetylase inhibitors suppress telomerase reverse transcriptase mrna expression in prostate cancer cells.

Published in:

International Journal of Cancer, 2002, v. 97, n. 5, p. 621, doi. 10.1002/ijc.10082

By:

Suenaga, Mitsuhiro;
Soda, Hiroshi;
Oka, Mikio;
Yamaguchi, Akihiko;
Nakatomi, Katsumi;
Shiozawa, Ken;
Kawabata, Shigeru;
Kasai, Takashi;
Yamada, Yasuaki;
Kamihira, Shimeru;
Tei, Chuwa;
Kohno, Shigeru

Publication type:

Article